Prelude Therapeutics, Inc. (PRLD)
3.26
-0.06
(-1.81%)
USD |
NASDAQ |
Oct 16, 16:00
3.25
-0.01
(-0.31%)
After-Hours: 20:00
Prelude Therapeutics Cash and Short Term Investments (Quarterly) : 151.76M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 151.76M |
| March 31, 2026 | 81.55M |
| December 31, 2025 | 103.21M |
| September 30, 2025 | 54.96M |
| June 30, 2025 | 73.22M |
| March 31, 2025 | 99.07M |
| December 31, 2024 | 133.61M |
| September 30, 2024 | 153.63M |
| June 30, 2024 | 179.84M |
| March 31, 2024 | 201.92M |
| December 31, 2023 | 232.94M |
| September 30, 2023 | 230.51M |
| June 30, 2023 | 254.99M |
| March 31, 2023 | 172.26M |
| Date | Value |
|---|---|
| December 31, 2022 | 201.73M |
| September 30, 2022 | 224.04M |
| June 30, 2022 | 246.30M |
| March 31, 2022 | 266.19M |
| December 31, 2021 | 291.23M |
| September 30, 2021 | 320.86M |
| June 30, 2021 | 343.12M |
| March 31, 2021 | 362.99M |
| December 31, 2020 | 218.31M |
| September 30, 2020 | 234.79M |
| June 30, 2020 | 29.72M |
| March 31, 2020 | |
| December 31, 2019 | 18.88M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Q32 Bio, Inc. | 106.27M |
| Intellia Therapeutics, Inc. | 437.76M |
| Twist Bioscience Corp. | 166.84M |
| Beam Therapeutics, Inc. | 1.153B |
| Revolution Medicines, Inc. | 3.938B |